Ubs Asset Management Americas Inc Enanta Pharmaceuticals Inc Transaction History
Ubs Asset Management Americas Inc
- $277 Billion
- Q1 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 208,089 shares of ENTA stock, worth $2.7 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
208,089
Previous 224,069
7.13%
Holding current value
$2.7 Million
Previous $2.11 Million
72.34%
% of portfolio
0.0%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding ENTA
# of Institutions
108Shares Held
21.7MCall Options Held
9.4KPut Options Held
3.3K-
Farallon Capital Management LLC San Francisco, CA2.1MShares$27.2 Million0.17% of portfolio
-
Morgan Stanley New York, NY2.05MShares$26.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.93MShares$25 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.84MShares$23.9 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY1.24MShares$16 Million0.29% of portfolio
About ENANTA PHARMACEUTICALS INC
- Ticker ENTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,724,900
- Market Cap $269M
- Description
- Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...